555 related articles for article (PubMed ID: 25688886)
1. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
2. In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
Anaerobe; 2015 Aug; 34():132-8. PubMed ID: 26028405
[TBL] [Abstract][Full Text] [Related]
3. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Köhler GA; Assefa S; Reid G
Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
[TBL] [Abstract][Full Text] [Related]
4. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
5. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
7. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Söderling EM; Marttinen AM; Haukioja AL
Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
[TBL] [Abstract][Full Text] [Related]
8. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.
Martinez RC; Franceschini SA; Patta MC; Quintana SM; Gomes BC; De Martinis EC; Reid G
Can J Microbiol; 2009 Feb; 55(2):133-8. PubMed ID: 19295645
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates.
Santos RB; Scorzoni L; Namba AM; Rossoni RD; Jorge AOC; Junqueira JC
Med Mycol; 2019 Apr; 57(3):391-394. PubMed ID: 29796666
[TBL] [Abstract][Full Text] [Related]
10. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.
Matsubara VH; Wang Y; Bandara HMHN; Mayer MPA; Samaranayake LP
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6415-6426. PubMed ID: 27087525
[TBL] [Abstract][Full Text] [Related]
11. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus fermentum Ess-1 with unique growth inhibition of vulvo-vaginal candidiasis pathogens.
Rönnqvist D; Forsgren-Brusk U; Husmark U; Grahn-Håkansson E
J Med Microbiol; 2007 Nov; 56(Pt 11):1500-1504. PubMed ID: 17965352
[TBL] [Abstract][Full Text] [Related]
13. Effect of Oral Probiotic
Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations.
Verdenelli MC; Coman MM; Cecchini C; Silvi S; Orpianesi C; Cresci A
J Appl Microbiol; 2014 May; 116(5):1297-307. PubMed ID: 24552173
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Controlled Open Label Crossover Trial to Study Vaginal Colonization of Orally Administered Lactobacillus Reuteri RC-14 and Rhamnosus GR-1 in Pregnant Women at High Risk for Preterm Labor.
Yefet E; Colodner R; Strauss M; Gam Ze Letova Y; Nachum Z
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325794
[TBL] [Abstract][Full Text] [Related]
16. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
Boahen A; Chew SY; Neela VK; Than LTL
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
[TBL] [Abstract][Full Text] [Related]
17. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.
Keller MK; Hasslöf P; Stecksén-Blicks C; Twetman S
Acta Odontol Scand; 2011 Sep; 69(5):263-8. PubMed ID: 21306197
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions.
Jiang Q; Stamatova I; Kari K; Meurman JH
Benef Microbes; 2015; 6(3):361-8. PubMed ID: 25380800
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
